To further assess the effect of MEK1/2 and CDK4 on the growth of ESCC, we respectively generated cell lines with MEK1, MEK2, or CDK4 knockdown (Fig. 5A). Here, MAP2K2 is linked to esophageal squamous cell carcinoma.